Datos a fecha 02/05/26 01:42
| Ticker | VTYX |
|---|---|
| ISIN | US92332V1070 |
| Sector | Tecnología |
| Industria | Biotechnology |
| Mercado | NASDAQ |
| Capitalización | 1.004.502.072 € |
| Beta | 1,27 |
| Sitio web | https://www.ventyxbio.com |
| CEO | Sheila K. Gujrathi |
| Fecha de IPO | 21/10/2021 |
| País | US |
| Dirección | 662 Encinitas Boulevard, San Diego, CA, 92024 |
| Volumen | 5.403.471 |
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis, inflammatory bowel disease, psoriatic arthritis, Crohn's disease, and lupus. It also develops VTX002, an oral sphingosine 1 phosphate receptor 1 mod...
El precio actual de Ventyx Biosciences, Inc (VTYX) es de 14,00 , con una variación del 0,00%.
Ventyx Biosciences, Inc opera en el sector Healthcare, industria Biotechnology.
Compara brokers con acceso a las principales bolsas internacionales, con bajas comisiones, custodia y herramientas de análisis para invertir en acciones.
Compara brokers para acciones